Doctors report rising hip replacements among young Indians post-COVID, linking steroid use and avascular necrosis to severe ...

Doctors across India are reporting a worrying rise in hip damage among younger adults after the COVID-19 pandemic. Experts say delayed diagnosis, sedentary lifestyles, and excessive steroid use during ...

Parents and former employees say there is minimal treatment and barely any schooling, with only young, poorly trained staff to supervise the kids. Two mothers described it as something out of “Lord of ...

US FDA grants accelerated approval to Gilead’s Hepcludex for the treatment of chronic hepatitis delta virus: Foster City, California Tuesday, May 26, 2026, 10:00 Hrs [IST] Gilea ...

Last May 17, 2026, the World Health Organization Director General Tedros Ghebreyesus declared the ongoing epidemic of the Bundibugyo strain of the Ebola ...

She’d given birth to her son in December 2021 before catching Covid-19 just three days later. The tiredness that followed made her feel miserable but she wasn’t overly alarmed. The 42 year-old from ...

New results from the Phase 3 SUNRISE clinical trial show that tezepelumab significantly reduced the need for long-term oral ...

COVID-19 can sometimes be treated at home. Understand emergency symptoms to watch for, how to protect others if you're ill, how to protect yourself while caring for a sick loved one and other coping ...

The true toll of long COVID may be double that of current estimates and hidden from current surveillance systems that rely on ...

The true toll of long COVID may be double that of current estimates and hidden from current surveillance systems that rely on ...

Combination tobevibart 300 mg + elebsiran 200 mg q4w achieved HDV RNA TND in 77% at week 72 and 88% at week 96, outperforming tobevibart monotherapy. Profound HBsAg lowering occurred with dual therapy ...

The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) driven by EGFR ...